Industry Briefs: December 3, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: December 3, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

AMRI will close its Bothell, Washington, site, and transition the site’s drug-discovery capabilities to Singapore while certain analytical capabilities will consolidate into the company’s analytical quality group in Albany, New York. Read More

Aptiv Solutions has opened a new laboratory and office in Durham, North Carolina. Read More

Bend Research, PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) have developed a new technology for the production of thermostable vaccines. Read More

biOasis Technologies has entered into a research collaboration agreement with UCB to evaluate biOasis’s Transcend technology in the area of the delivery of therapeutic compounds to the brain. Read More

Capsugel has doubled its laboratory capacity with the opening of its new quality-control laboratory in Greenwood, South Carolina. Read More

Covance’s early-development facility in Shanghai, China, has received a Good Laboratory Practice Certificate from China’s State Food and Drug Administration. Read More

Dalton Pharma Services has added size-exclusion chromatography (SEC) - multi angle (laser) light-scattering (MALS) large-molecule testing services. Read More

Galena Biopharma has signed an agreement with a subsidiary of Teva Pharmaceutical Industries for the commercialization of NeuVax (nelipepimut-S or E75) in Israel. Read More

Hovione and Solvias have announced a collaboration focused on the development and GMP supply of pharmaceutical cocrystals. Read More

NextPharma has completed the sale of its Bioserv, its US affiliate, to KESA Partners. Read More

Noven Pharmaceuticals has acquired commercial rights to Minivelle (estradiol transdermal system) in the US and Canada. Read More

Recipharm has invested to expand its capacity in analytical services and stability studies at its facility in Solna, Sweden. Read More

Single Cell Technology and Open Monoclonal Technology have announced a human antibody discovery and development collaboration. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search

Click here